![]()
|
Report Date : |
19.02.2008 |
IDENTIFICATION
DETAILS
|
Name : |
LIPTIS EGYPT FOR PHARMACEUTICAL PRODUCTS CO |
|
|
|
|
Registered Office : |
65
Manial Street, El Pasha Square, Manial, Cairo |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Date of Incorporation : |
2004 |
|
|
|
|
Com. Reg. No.: |
48828 |
|
|
|
|
Legal Form : |
Limited Liability Partnership |
|
|
|
|
Line of Business : |
Manufacture of pharmaceutical preparations. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 250,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
Company Name :
LIPTIS
EGYPT FOR PHARMACEUTICAL
PRODUCTS CO
Also Known As : LIPTIS EGYPT CO
Country of Origin : Egypt
Legal Form : Limited Liability Partnership
Registration Date : 2004
Commercial Registration Number : 48828
Tax Card Number : 431-157-022
Issued Capital : £E 10,000,000
Paid up Capital : £E 10,000,000
Total Workforce : 250
Line of Business : Manufacture of pharmaceutical preparations.
Financial Condition : Undetermined
Payments : Nothing detrimental uncovered
LIPTIS EGYPT FOR PHARMACEUTICAL PRODUCTS CO
LIPTIS EGYPT CO
Street : 65
Manial Street
Area : El
Pasha Square, Manial
Town : Cairo
Country : Egypt
Telephone : (20-2) 25310174
Facsimile : (20-2) 23687847
Subject operates from
a large suite of offices that are rented and located in the Suburban Business
Area of Cairo.
Location Description
·
6th
Industrial Zone, Area B2 Factory
premises
6th
of October City
·
Dr.
Lotfy Ismail Omar Managing
Partner
·
Dr.
Ahmed Samir General
Manager
·
Nasr
Hassan Finance
Manager
·
Mohamed
Alaa Administration
Manager
·
Mohamed
Nabil Purchasing
Manager
·
Ali
Fathy Revenue
Manager
Date of Establishment : 2004
Legal Form :
Sharikat Tadhamun Bill
Asshum (Limited Liability
Partnership)
Commercial Reg. No. : 48828
Tax Card No. : 431-157-022
Issued Capital : £E 10,000,000
Paid up Capital : £E 10,000,000
·
Dr.
Lotfy Ismail Omar
·
Members of Dr. Lotfy Ismail Omar’s family
Operations : Engaged in the
manufacture of pharmaceutical preparations. Subject is currently in the process
of launching a new production line for baby milk under licence of Hok Dorf
(Switzerland). It is expected to be fully operation in 2009.
Import Countries
: Switzerland and Egypt.
Subject has a
workforce of approximately 250 employees.
Companies registered
in Egypt are not legally required to make their accounts public and no
financial information was released by the company or submitted by outside
sources.
·
Export
Development Bank of Egypt
108 Mohi El Din Abu El Ezz Street
Mohandessin
Cairo 11111
Tel : (20-2) 3619005 / 3385877
Fax : (20-2) 3385940 / 3385938
No complaints
regarding subject’s payments have been reported.
Opinion on the
credit figure of US$ 100,000:
During the course of
this investigation nothing detrimental was uncovered regarding subject’s
operating history or the manner in which payments are fulfilled. As such the
company is considered to be a fair trade risk and the above credit figure is
within subject’s financial means.
Maximum suggested
credit figure: US$ 250,000
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)